PF-Atlas › Clinical Trials › NCT01414257
Methotrexate High Dose Special Investigation
Methotrexate · Not specified
Registry ID
NCT01414257
Phase
Not specified
Status
Completed
Drug / intervention
Methotrexate (MTX)
Sponsor
Pfizer
Start
2011-05
Enrollment
2860
Locations
1
About this trial
This Investigation is to be performed for the purpose of assessing the following information in the long-term post-marketing daily medical practice in the patients who receive REUMATOLEX 2 mg Capsule for the treatment of Rheumatoid Arthritis (RA) at the dose higher than 8 mg/week. 1. Condition of occurrence of ADRs 2. Factors considered to affect safety 3. Verification of efficacy
Explore related
Medical disclaimer. This page summarizes public trial data for NCT01414257 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.